Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 23;21(5):36.
doi: 10.1007/s11920-019-1015-2.

Epidemiological and Clinical Gender Differences in OCD

Affiliations
Review

Epidemiological and Clinical Gender Differences in OCD

Brittany M Mathes et al. Curr Psychiatry Rep. .

Abstract

Purpose of review: This review highlights recent research regarding gender differences in OCD, with a focus on prevalence, course of illness, symptom presentation, comorbidity, and treatment response.

Recent findings: Overall, findings remain mixed. OCD may be more common among males in childhood, but is more common among females in adolescence and adulthood. Males tend to report an earlier age of onset and present with symptoms related to blasphemous thoughts. Females often describe symptom onset as occurring during or after puberty or pregnancy and present with symptoms related to contamination and/or aggressive obsessions. Females also tend to report significantly higher depression and anxiety. There are no reported gender differences in treatment outcome. Gender may play a role in the onset, presentation, and impact of OCD symptoms. However, more work is needed to account for differences across studies, with one promising future direction being the study of reproductive hormones.

Keywords: Epidemiology; Exposure and response prevention; Gender differences; Obsessive-compulsive disorder.

PubMed Disclaimer

References

    1. Compr Psychiatry. 2014 Oct;55(7):1513-9 - PubMed
    1. Psychiatr Clin North Am. 2006 Jun;29(2):353-70 - PubMed
    1. J Affect Disord. 2013 Sep 25;150(3):847-54 - PubMed
    1. Neuropharmacology. 2018 Mar 15;131:104-115 - PubMed
    1. Int J Psychiatry Clin Pract. 2013 Aug;17(3):188-96 - PubMed

LinkOut - more resources